US2024000881A1PendingUtilityA1

Topical treatment for animals

Assignee: LAAU INCPriority: Nov 6, 2019Filed: May 18, 2023Published: Jan 4, 2024
Est. expiryNov 6, 2039(~13.3 yrs left)· nominal 20-yr term from priority
A61K 36/886A61K 33/04A61K 31/716A61K 47/06A61P 17/02A61K 9/1688A61K 2236/31A61K 9/0017A61K 9/06
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A topical formulation and method of using the formulation on animals including dogs is disclosed. The formulation is used to facilitate the healing of cuts, scrapes, abrasions, and other conditions often experienced by animals. A main ingredient of the formulation is sulfur in a high concentration.

Claims

exact text as granted — not AI-modified
It is claimed: 
     
         1 . A topical treatment for the treatment of animal wounds comprising:
 30%-33% sulfur;   30%-33%  Aloe vera  or  Aloe vera  derivative;   30-33% hydrocarbon polymer;   At most 5% impurities.   
     
     
         2 . The topical treatment of  claim 1  wherein the  Aloe vera  derivative may be selected from a group consisting of  Aloe vera  gel,  Aloe vera  powder,  Aloe vera  extract, Veracylglucan (C 56 H 82 O 51 ), Acemannan C 66 H 10 1NO 49 ; wherein the hydrocarbon polymer may be selected from the group consisting of petroleum jelly hydrogenated castor oil and beeswax. 
     
     
         3 . The topical treatment of  claim 1  wherein the sulfur comes in the form of S 8 . 
     
     
         4 . The topical treatment of  claim 1  wherein the  Aloe vera  or  Aloe vera  derivative further comprises at least 30 micrograms of Veracylglucan, at least 10 micrograms of Acemannan, and 30 grams of  Aloe vera  plant extract. 
     
     
         5 . The topical treatment of  claim 1  wherein the  Aloe vera  or  Aloe vera  derivative is obtained from a plant species within the  Aloe  family, the plant further comprising  Aloe vera, Aloe viridiflora, Aloe excelsa, Aloe thraskii , and  Aloe namibensis.    
     
     
         6 . The topical treatment of  claim 1  wherein the impurities further comprise amylase selected from the group of sequence IDs consisting of SEQUENCE ID 1, SEQUENCE ID 2, SEQUENCE ID 3, SEQUENCE ID 4, SEQUENCE ID 5, or SEQUENCE ID 6. 
     
     
         7 . A method of applying a therapeutically effective amount of a topical treatment for an animal wound on an animal in need thereof comprising:
 selecting an individual animal from a group or herd of animals;   consulting the animal's medical history and verifying that the animal does not have a disease affecting blood pressure, muscles, or neural cells;   measuring the wound;   dolling out an appropriate amount of TPA based on the wound measurement;   cleaning the wound and shaving off hair feathers, scales, fur, hair, exoskeleton or other integument, but not disturbing the animal's natural oils or secretions;   applying an effective amount of TPA to the wound site;   reapplying TPA every day for at least two weeks;   verifying that the wound has significantly decreased;   reapplying TPA until the wound has significantly decreased.   
     
     
         8 . The method of  claim 7  in wherein the TPA is a topical treatment for the treatment of animal wounds comprising:
 30%-33% sulfur; 
 30%-33%  Aloe vera  or  Aloe vera  derivative; 
 30-33% hydrocarbon polymer; 
 at most 5% impurities. 
 
     
     
         9 . The method of  claim 7  wherein the TPA contains  Aloe vera  extract, Veracylglucan (C 56 H 82 O 51 ), Acemannan C 66 H 101 NO 49 . 
     
     
         10 . The method of  claim 7  wherein the TPA contains  Aloe vera  obtained from an  Aloe  plant of the species  Aloe vera, Aloe viridiflora, Aloe excelsa, Aloe thraskii , and  Aloe namibensis.    
     
     
         11 . A method of producing TPA comprising: selecting a specimen of  Aloe vera  from an  Aloe  plant;
 de-dusting the  Aloe vera  specimen;   washing the  Aloe vera  specimen in warm water, the warm water being exposed to the  Aloe vera  plant for at least five seconds;   removing the rind from the  Aloe vera  specimen;   washing the specimen a second time in warm water, the warm water being exposed to the  Aloe vera  plant for at least five seconds;   inserting the specimen into a dehydrating machine for at least twelve hours;   examining the  Aloe vera  specimen and verifying that the specimen is no more than 5% liquid by weight and modifying the specimen if there is more than 5% liquid by dry weight;   grinding up the  Aloe vera  specimen until it is a fine powder of  Aloe vera  granules;   mixing the  Aloe vera  granules with wet  Aloe vera  extract to create a dry-wet  Aloe vera  complex;   mixing the dry-wet  Aloe vera  complex with sulfur until the mixture becomes a homogeneous mixture of sulfur and granules;   combining the homogeneous mixture with petroleum jelly and homogenizing the homogeneous mixture with the petroleum jelly until the entire mixture becomes homogenous TPA with no more than 1% impurities.   
     
     
         12 . The method of  claim 11  wherein inserting the specimen into a dehydrating machine further comprises 135° F.-200° F. for six hours. 
     
     
         13 . The method of producing TPA in  claim 11  wherein the sulfur is S 8 . 
     
     
         14 . The method of producing TPA in  claim 11  wherein the  Aloe vera  specimen is configured to contain at least 30 mg of Veracylglucan (C 56 H 82 O 51 ) and 30 mg of Acemannan C 66 H 10 1NO 49 . 
     
     
         15 . The method of producing TPA in  claim 11  wherein the granules have a diameter of 30-40 μm. 
     
     
         16 . The method of producing TPA in  claim 11  wherein the fine powder  Aloe vera  granules constitute between 30%-40% of the final TPA; the sulfur constitutes 30-40% of the final TPA the petroleum jelly constitutes 30%-40% of the final TPA. 
     
     
         17 . The method of  claim 11  in which the specimen of  Aloe vera  is selected from a plant within the species of  Aloe vera, Aloe viridiflora, Aloe excelsa, Aloe thraskii , and  Aloe namibensis.    
     
     
         18 . The method of  claim 11  wherein the impurities further comprise amylase. 
     
     
         19 . The method of  claim 11  wherein the impurities are selected from the group of sequence IDs consisting of SEQUENCE ID 1, SEQUENCE ID 2, SEQUENCE ID 3, SEQUENCE ID 4, SEQUENCE ID 5, or SEQUENCE ID 6. 
     
     
         20 . The method of  claim 11  wherein the impurities consist essentially of SEQUENCE ID 6.

Join the waitlist — get patent alerts

Track US2024000881A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.